Novartis in the Philippines was incorporated in 1996, following the merger of the global parent companies Ciba-Geigy and Sandoz. Novartis Healthcare Philippines, Inc. is one of the leading research-based pharmaceutical companies in the country, providing innovative, life-saving medicines to patients.
Novartis has made substantial contributions to support the Philippine economy and improve health outcomes of Filipinos:
In 2022, Novartis contributed PHP 7.5 billion to the Gross Domestic Product (GDP) of the Philippines. Nineteen percent of the company's total GDP contribution stems from innovation.